BIOMAT Database Logo BIOMAT Database Logo

A clinical staging system for chronic lymphocytic leukemia: prognostic significance. 1977

J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002699 Chlorambucil A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed) 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid,Amboclorin,CB-1348,Chloraminophene,Chlorbutin,Leukeran,Lympholysin,N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid,NSC-3088,CB 1348,CB1348,NSC 3088,NSC3088
D005260 Female Females

Related Publications

J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Prognostic factors and clinical staging in chronic lymphocytic leukemia.
April 1990, Hematology/oncology clinics of North America,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Clinical staging and prognostic markers in chronic lymphocytic leukemia.
August 2004, Hematology/oncology clinics of North America,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Chronic lymphocytic leukemia: staging and prognostic factors.
February 1998, Seminars in oncology,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Clinical staging of chronic lymphocytic leukemia.
September 1977, The Journal of the Maine Medical Association,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Clinical staging of chronic lymphocytic leukemia.
August 1975, Blood,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
[Prognostic value of the clinical staging of chronic lymphocytic leukemia (author's transl)].
August 1979, Haematologica,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance.
December 2010, Blood,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
Staging of chronic lymphocytic leukemia.
June 1982, Blood,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
June 2021, American journal of hematology,
J L Binet, and M Leporrier, and G Dighiero, and D Charron, and P D'Athis, and G Vaugier, and H M Beral, and J C Natali, and M Raphael, and B Nizet, and J Y Follezou
[Prognostic significance of nucleolar markers in chronic lymphocytic leukemia].
November 1990, Gematologiia i transfuziologiia,
Copied contents to your clipboard!